Pulse Biosciences to Host Quarterly Investor Conference Call on November 7, 2017
October 24 2017 - 5:00PM
Business Wire
Pulse Biosciences, Inc., (Nasdaq: PLSE) a medical technology
company developing a proprietary therapeutic tissue treatment based
on its Nano-Pulse Stimulation (NPS) platform, today announced it
will host its quarterly investor conference call on Tuesday,
November 7, 2017 at 1:30 p.m. PST / 4:30 p.m. EST.
Conference Call Details
Analysts and investors can participate in the conference call by
dialing (844) 494-0190 (U.S. toll-free) or (508) 637-5580
(international) using Conference ID 1522560. Listeners will also be
able to access the call via webcast available on the Investor
Section of the company’s website
at www.pulsebiosciences.com.
About Pulse Biosciences
Pulse Biosciences is a medical technology company developing a
therapeutic tissue treatment platform based on Nano-Pulse
Stimulation, a proprietary cell signaling technology. Nano-Pulse
Stimulation is a non-thermal, precise, focal drug-free tissue
treatment technology that directly affects the cell membrane and
intracellular structures to stimulate unique behaviors in cells.
NPS can initiate a cell death process that allows for the treatment
of tissue cells with minimal inflammatory response which improves
healing outcomes and supports the replacement of treated tissue
cells with healthy tissue cells. In cancerous lesions, NPS has been
shown in preclinical models to induce immunogenic cell death (ICD),
exposing the unique antigens of the treated cells to the immune
system. This process results in the generation of cytotoxic T-cells
and the mounting of an adaptive immune response targeted against
those cells. Pulse Biosciences is investigating a variety of
applications for its technology that exploits the technology’s
unique biologic effect, including immuno-oncology, dermatology and
veterinary medicine. More information is available at
www.pulsebiosciences.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20171024006674/en/
Investors:Pulse Biosciences, Inc.Brian Dow, SVP and Chief
Financial OfficerIR@pulsebiosciences.comorThe Trout GroupMike
Zanoni, 646-378-2924mzanoni@troutgroup.comorMedia:Sam Brown,
Inc.Christy Curran, 615-414-8668christycurran@sambrown.com
Pulse Biosciences (NASDAQ:PLSE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Pulse Biosciences (NASDAQ:PLSE)
Historical Stock Chart
From Apr 2023 to Apr 2024
